Lexington Biosciences Holdings Corp LXGTF

Financial Services Asset Management

Lexington Biosciences Holdings Corp., formerly Lexington Biosciences Inc., is a Canada-based medical device company, which core business is to develop and commercialize non-invasive diagnostic product HeartSentry to monitor cardiovascular health by assessing the function of a person’s vascular endothelium - the vital innermost lining of a person’s cardiovascular system. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The company is in the final stages of releasing the developed product for clinical studies. The Company's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.

GREY:LXGTF - Post by User

Lexington Biosciences Holdings Corp

<< Previous

Bullboard Posts

Next >>

Post by CatamaranFundon Apr 08, 2019 1:18pm

144 Views

Post# 29597477

1 (new) for 10 (old) Reverse Split - A lifejacket?

Now also posted on Lexington site here:
https://lexingtonbiosciences.com/news/lexington-biosciences-provides-update-on-financial-situation/

A little about reverse splits here:
https://finance.zacks.com/reverse-stock-split-good-bad-2298.html

Reverse Splits Aren't All Bad - Not every company's going for fewer shares at higher price points ends badly.

1-for-10 reverse split1-for-10 reverse split
https://www.fool.com/investing/general/2012/03/20/reverse-splits-arent-all-bad.aspx

A reverse stock split is generally considered a positive for several reasons:
https://www.sapling.com/7264923/reverse-stock-split-good-bad

This gives Lexington a chance to survive ( and thrive)

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition